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INTRODUCTION
Ovarian cancer is a primary malignancy of the
ovary.1 Approximately 192.000 new cases are dis-
covered per year worldwide.2 In United State, the
prevalence of ovarian cancer is 23.100 cases per
year, while in United Kingdom is 6.000 cases.3,4 In
Indonesia, according to the National Cancer Regis-
try Indonesian Society of Gynecological Oncology
(INASGO)5, from 2000 - 2013, approximately 2930
cases were discovered. Ovarian cancer is the third
most common malignancy in women after cervical
and breast cancer.6
Survival rate of ovarian malignancy is very poor,
a study was done in United Kingdom demonstrated
that 5-years survival rate of early ovarian cancer
was 73%, while in the advanced stage was 16%.7
According to this study, it is important to detect in
early stage, since delay in diagnosis correlates with
Abstract
Objective: To compare diagnostic performance of International
Ovarian Tumor Analysis (IOTA) scoring method with Risk of Malig-
nancy Index-4 (RMI-4) and Sassone Morphology Index to predict
ovarian malignancy preoperatively.
Method: Retrospective study with 119 subject who underwent sur-
gical removal of ovarian tumor and performed histopathological
examination at Dr. Cipto Mangunkusumo Hospital on January to
December 2013. Demographic status, ultrasound scans, CA-125
level and histopathological result were collected to calculate the
score of each method. Sensitivity, specificity, positive predictive
value, negative predictive value and accuracy were calculated by
comparing each score with histopathology result. Comparison of
diagnostic performance was analyzed by ROC curve.
Result: There were 51.26% subjects with benign tumor and 48.74%
subjects with malignant tumor. Result was analyzed with sensitivity
test (IOTA simple-rules, IOTA subgroup, RMI-4 and Sassone): 98%,
88%, 86% and 79%; specificity: 74%, 67%, 61% and 89%; positive
predictive value: 78%, 72%, 68% and 87%; negative predictive
value: 98%, 85%, 82% and 81%; and accuracy: 86%, 77%, 73% and
84%. AUC value for IOTA simple-rules, IOTA subgroup, RMI-4 and
Sassone were: 0.86, 0.78, 0.73 and 0.84. Comparison of these results
were significant with p = 0.000.
Conclusion: IOTA simple-rules had better sensitivity, negative pre-
dictive value and accuracy than IOTA subgroup, RMI-4 and Sassone
morphology index to predict ovarian malignancy preoperatively.
[Indones J Obstet Gynecol 2016; 1: 42-46]
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Abstrak
Tujuan: Membandingkan kemampuan diagnostik metode skoring In-
ternational Ovarian Tumor Analysis (IOTA) dengan Risk of Malig-nancy Index-4 (RMI-4) dan Sassone Morphology Index dalam mem-
prediksi keganasan ovarium prabedah.
Metode: Uji diagnostik secara retrospektif pada 119 pasien yang men-
jalani pembedahan atas indikasi neoplasma ovarium dan dilakukan
pemeriksaan histopatologi di RSUPN Dr. Cipto Mangunkusumo dariJanuari hingga Desember 2013. Data demografi, ultrasonografi dan
kadar CA-125 dikumpulkan untuk dikelola menurut metode skoringIOTA simple-rules, IOTA subgroup, RMI-4 serta Sassone dan diban-
dingkan dengan histopatologi. Nilai diagnostik dari keempat metode
skoring dihitung dengan luaran: sensitivitas, spesifisitas, nilai prediksipositif, nilai prediksi negatif dan akurasi. Perbandingan ketiganya di-
hitung menggunakan kurva ROC.
Hasil: Didapati 51,26% subjek dengan tumor jinak dan 48,74% subjek
dengan tumor ganas. Dari perhitungan, didapat sensitivitas IOTA simple-rules, IOTA subgroup, RMI-4 dan Sassone adalah: 98%, 88%, 86% dan
79%. Spesifisitas: 74%, 67%, 61%, dan 89%. Nilai prediksi positif: 78%,
72%, 68%, dan 87%. Nilai prediksi negatif: 98%, 85%, 82%, dan 81%.Akurasi: 86%, 77%, 73% dan 84%. Nilai AUC IOTA simple-rules, IOTA
subgroup, RMI-4 dan Sassone adalah: 0,86; 0,78; 0,73 dan 0,84. Perban-
dingan keempat nilai AUC ini memberikan hasil bermakna p = 0,000.
Kesimpulan: IOTA simple-rules memiliki sensitivitas, nilai prediksi ne-gatif dan akurasi lebih baik dibandingkan IOTA subgroup, RMI-4 dan
Sassone Morphology Index dalam memprediksi keganasan ovarium
prabedah.
[Maj Obstet Ginekol Indones 2016; 1: 42-46]
Kata kunci: iota, kanker ovarium, keganasan ovarium, skoring, tumor
ovarium
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delay in treatment and more over poorer in prog-
nosis. To minimize delay in diagnosis, it is impor-
tant to evaluate the ovarian tumor whether it is a
benign or malignant, because it will facilitate the
referral to the tertiary level.
Ultrasonography has developed many scoring
systems to predict ovarian malignancy, which is:
Sassone Morphology Index (1991), Risk of Malig-
nancy Index (Jacob, 1991), and International Ova-
rian Tumor Analysis (IOTA, 2000-2013).8 Each of
the scoring system has good sensitivity and speci-
ficity in predicting malignancy in ovarian tumor.
Unfortunately, there is no data that compare the
diagnostic performance of each scoring systems
and its applicability in Indonesian population.
Therefore, this study aims to demonstrate the
diagnostic performance of IOTA, Sassone Mor-
phology Index and RMI-4.
METHODS
This was a retrospective study with subject popu-
lation was patients who underwent surgical re-
moval of ovarian tumor and histopathological
examination in National General Hospital Dr. Cipto
Mangunkusumo on January to December 2013.
Medical records, along with the ultrasound scans,
were reviewed by gynecological oncology consul-
tant. Incomplete medical records or ultrasound
scans and borderline histopathology tumor were
excluded from this study.
Each scoring method was calculated on every
subjects, based on IOTA simple-rules, IOTA sub-
group, Sassone Morphology Index and RMI-4 to
evaluate the tumor for malignancy possibility. The
reference standard of this study was histopatho-
logy examination using World Health Organization
classification. The operational definition of IOTA
simple-rules, subgroup, RMI-4 and Sassone Mor-
phology Index can be found on Table 1, 2, 3 and
Figure 1. The outcome of the study was sensitivity,
specificity, positive predictive value, negative pre-
dictive value and accuracy that were performed by
ROC curve. Statistical significancy was determined
by p value < 0.05. SPSS v.21 was used to do the
statistical calculation.
Figure 1. Sassone morphology index12
Benign if score < 9; Malignant if ≥ 9
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Table 2. IOTA subgroup10
Unilocular Multilocular Solid component, no papillation Papillation
Weight Weight Weight
Ascites 2 Ascites 7 Ascites 3
Number of locules 1 Irregular wall and: Age ≥ 50 years 1
Max lesion D ≥ 100 mm 1 Completely solid tumor 5 Number of papillations ≥ 4 2
Age ≥ 50 years 1 Multilocular solid with
max lesion D ≥ 100 mm
3 Papillary flow 2
Other 1
Blood flow color score: Blood flow color score:
No flow -4 Very strong flow 2
Minimal flow -1
Moderately strong flow 0
Very strong flow 2
Max solid D: Max solid D:
< 10 mm -3 < 10 mm -3
10-19.9 mm -1 10-19.9 mm -1
20-29.9 mm 0 20-29.9 mm 0
30-39.9 mm 1 30-39.9 mm 1
40-49.9 mm 2 40-49.9 mm 2
≥ 50 mm 3 ≥ 50 mm 3
Bilateral 2
Acoustic shadow -3 Acoustic shadow -3
Personal history of
ovarian cancer
3
Total < 3 → benign Total < 4 → benign Total < 2 → benign
Benign Total ≥ 3 → malignant Total ≥ 3 → malignant Total ≥ 3 → malignant
Table 1. IOTA Simple-rules9
B­rules M­rules
Unilocular Irregular solid
Solid part with diameter < 7 mm Ascites
Multilocular with regular border size < 100 mm Multilocular with irregular border > 100 mm
Acoustic shadow At least 4 papillary projections
No blood flow Strong blood flow
Table 3. RMI-411
RMI­4
U x M x S x CA125
U Parameters: solid, multilocular, bilateral, ascites, metastasisUltrasound score: 1 or 4. Put 1 if ≤ 1 parameters, 4 if > 1 parameters
M Menopausal status: 1 or 4. Put 1 if premenopause, 4 if post menopause
S Size of tumor mass: 1 or 2. Put 1 if size < 7 cm, 2 if size ≥ 7 cm
CA125 CA125 value
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RESULTS
From this study, we confirmed that 61 (51.26%)
subjects with benign tumor and 58 (48.74%) sub-
jects with malignant tumor, with approximately
69% of the population were aged above 40 years
and 4.2% were aged below 19 years. Mean size of
tumor was 152 mm (50 - 480 mm) for benign and
139 mm (53 - 450 mm) for malignant tumor and
the mean value of CA-125 was 129 U/ml (5 - 816
U/ml) for benign and 658 U/ml (7 - 7490 U/ml)
for malignant tumor. The majority of the popula-
tion with benign and malignant tumor was found
in premenopausal status (68.9% and 58.6%, p =
0.246).
The scoring methods were applied to the sub-
jects and resulted with sensitivity (IOTA simple-
rules, IOTA subgroup, RMI-4 and Sassone): 98%,
88%, 86% and 79%; specificity: 74%, 67%, 61%
and 89%; positive predictive value: 78%, 72%,
68% and 87%; negative predictive value: 98%,
85%, 82% and 81%; and accuracy: 86%, 77%, 73%
and 84%. The AUC value for IOTA simple-rules,
IOTA subgroup, RMI-4 and Sassone were: 0.86,
0.78, 0.73 and 0.84 respectively. Comparison of
these results were significant with p = 0.000.
DISCUSSION
Compared with its predecessor study, the sensiti-
vity of IOTA simple rules in this study was quite
consistent. Timmerman et al9 demonstrated that
simple rules method had sensitivity of 95% and
specificity of 91%. Validation of this system by
Timmerman et al9 and Kaijser et al13 showed a sen-
sitivity of 90%. The specificity result of this study
was different from the initial study. There was a
20% difference. It can be explained from the mor-
phological characteristics of benign tumors that
truly benign and malignant tumors that suspected
benign. Approximately 43.8% of benign tumors
suspected malignancy had ascites, 31.3% had mul-
tilocular appearance with irregular border, 18.8%
had strong blood flow and 18.8% had papil more
than 4. These factors could contribute to increasing
the false-positive interpretation. Based on further
analysis, the presence of ascites correlated signifi-
cantly in improving the false-positive rate (r =
0412; p = 0.005).
The sensitivity of IOTA subgroup in this study
also had consistent result with previous research.
Ameye et al10 demonstrated that this subgroup
method had sensitivity of 88% and specificity of
90%. There was a 23% difference in the specificity
resulted from this study with the original research.
Morphological characteristic of the tumor was
also considered as a factor that increased the num-
ber of false-positives result in this group. In mul-
tilocular dominant appearance group of tumor,
37% histopathological benign multilocular tumor
was suspected malignant by this scoring method.
This was due to several factors such as: ascites,
number of locules, tumor size, and the age of the
patient. Approximately, 62.5% histopathological-
benign tumor which were suspected malignant had
locules more than 5.25% had ascites, 100% had
tumor size more than 100 mm, and 75% found in
subjects over 50 years. In tumors with solid ap-
pearance, 44% of histopathological benign tumors
Figure 2. ROC curve of each scoring method
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were suspected and classified as a malignancy. Ap-
proximately, 57% of this benign solid tumors had
ascites, irregular border (42.9%), and appearance
of blood flow (28.6%). In tumors with papillary
projection, 60% of histopathological benign tumor
were suspected malignant. All of histopathological
benign tumors with papillary projection which sus-
pected malignant had papil more than 4. The other
parameters which contribute to increasing number
of false-positives were: ascites (33.3%) and the ap-
pearance of blood flow (33.3%). Based on further
analysis, the presence of ascites had a significant
strong positive correlation in improving the false-
positive rate (r = 0667; p = 0.027).
The sensitivity results for RMI-4 in this popula-
tion was also consistent with previous research.
Yamamoto et al11 gained 86.8% sensitivity and
91% specificity. Wide differences between this
study and Yamamoto’s was also due to the charac-
teristic of the tumor, size of the tumor and meno-
pausal status. Approximately, 91.7% of histopa-
thological benign tumors were diagnosed as malig-
nant by RMI-4 had a tumor size above 100 mm,
41.7% of the population were in the post-
menopausal state. Ultrasound scoring equal to 4
was also contribute to 68.8% of this group. Based
on further analysis, ultrasound scoring equal to 4
had a weak positive correlation in increasing the
number of false-positive but it was not significant
(r = 0:25; p = 0.126).
Sassone’s previous studies obtained a sensitivity
of 100% and specificity of 83%.12 Geomini et al14
validated this scoring method and gained 84% sen-
sitivity and 83% specificity. This study found a
21% false-negative. This was also due to some
morphological characteristics of benign ovarian tu-
mors in histopathological malignant tumors. This
study found: 41.7% of tumors had regular wall,
50% with wall thickness less than 3 mm, and
41.7% had sonolucent or low echogenicity. Based
on further analysis, it was found that the wall thick-
ness of less than 3 mm had a weak positive corre-
lation in increasing the numbers of false-negative
(r = 0:25; p = 0.313).
The ROC curve showed that the AUC value of
IOTA simple-rules and Sassone morphology index
had over 80% (86% and 83%), demonstrating the
diagnostic test had a strong interpretation. While
IOTA subgroups and RMI-4 showed the AUC above
70% (78% and 73%) which showed moderate
interpretation.
CONCLUSION
IOTA simple rules scoring system had better sen-
sitivity, negative predictive value and accuracy
than RMI-4 and Sassone Morphology Index in pre-
dicting ovarian malignancy. Careful interpretation
needs to be done in a presence of ascites as this
was correlated with false-positive.
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